DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 8Dr. Reddy's Laboratories
02 1Olpha
03 6Granules India Limited
04 42care4
05 1Accord healthcare
06 2Adamed Pharma
07 1Alhavi Pharma
08 2Alkem Laboratories
09 1Alter Laboratories Sa
10 2Annora Pharma
11 1Aurobindo Pharma Limited
12 1Bausch Health
13 63Boehringer Ingelheim GmbH
14 3CLONMEL HLTHCARE
15 1Demo S.A.
16 3Grindeks AS
17 3Grupo Azevedos
18 4Intas Pharmaceuticals
19 1Intas Third Party Sales 2005 Sl
20 1InvaGen Pharmaceuticals Inc
21 2Kinapse
22 3Laboratorios Lafage
23 2MEDOCHEMIE LTD
24 6MSN Laboratories
25 1Mahban Group
26 4PharOS Ltd
27 5PharmaPath S.A.
28 4Pharmaline
29 1Pharmapath Sa
30 3Pluviaendo
31 3Prinston
32 5STADA Arzneimittel
33 8Sandoz B2B
34 3Sun Pharmaceutical Industries Limited
35 4Sunshine Lake Pharma
36 2Tecnimede
37 3Varian Pharmed
38 7Viatris
39 5Zentiva
40 4Zydus Pharmaceuticals
01 3Each Coated Tablet
02 81Film Coated Tablet
03 4Film Coated Tablet
04 6Immediate Release Tablet
05 1Linagliptin 5Mg 28 Combined Oral Use
06 1Metformin+Linagliptin+2,51,000 Mg 56 Combined Oral Use
07 1Metformin+Linagliptin+2,5850 Mg 56 Combined Oral Use
08 4Oral Solid Dosage Form
09 4TABLET
10 6TABLET, EXTENDED RELEASE;ORAL
11 4TABLET; ORAL
12 38TABLET;ORAL
13 19Tablet
14 2Tablets
15 1Tablets
16 2tablet
17 7Blank
01 5Allowed
02 10Approved
03 18Authorised
04 25Authorized
05 1Dossier Readiness: Q1 2025
06 2Generic
07 4Lead Market Dossiers- Filed
08 6Marketed
09 8Not Marketed
10 4Prescription
11 31RX
12 1Withdrawn
13 69Blank
01 1Diagliptin Deo
02 1Drojarto
03 3EMPAGLIFLOZIN AND LINAGLIPTIN
04 6EMPAGLIFLOZIN; LINAGLIPTIN
05 2Empagliflozin ; Linagliptin
06 1Empiria Complex
07 1Empiria Complex
08 2GLYXAMBI
09 2Girl Duet
10 2Glymetia
11 8Glyxambi
12 1Glyxambi
13 2Ilinpru
14 6JENTADUETO
15 2JENTADUETO XR
16 23Jentadueto
17 3Jentadueto mg
18 7LINAGLIPTIN
19 1LINAGLIPTIN 5
20 17LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
21 3LINAGLIPTIN; METFORMIN HYDROCHLORIDE
22 1Liglinra
23 1Linagliptin
24 3Linagliptin ; Metformin Hydrochloride
25 1Linagliptin Accord
26 1Linagliptin Intas
27 1Linagliptin Medochemie5
28 1Linagliptin Pharos
29 3Linagliptin Sandoz
30 1Linagliptin Stada
31 1Linagliptin Viatris
32 1Linagliptin Zentiva
33 3Linagliptin/Metformin Clonmel
34 3Linagliptin/Metformin Hcl Pharos
35 3Linagliptin/Metformin Sandoz
36 1Linagliptina Alter
37 1Linagliptina Medochemie
38 1Linagliptina Pharmapath
39 1Linagliptina Stada
40 2Linagliptina/Metformina Sandoz
41 2Linagliptine/Metformin Stada
42 1Linathan
43 2Meglithan
44 1Melijent
45 1TRADJENTA
46 1TRAJENTA
47 4TRIJARDY XR
48 8Trajenta
49 6Trajentamet
50 1Zyfoqam
51 33Blank
01 12Australia
02 4Canada
03 4Czech Republic
04 3Guatemala
05 14India
06 5Iran
07 3Italy
08 4Latvia
09 4Lebanon
10 19Malta
11 14Norway
12 2Poland
13 5Portugal
14 25Spain
15 10Sweden
16 5Switzerland
17 3Turkey
18 48USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;500MG
Packaging :
Approval Date : 2025-11-03
Application Number : 208427
Regulatory Info : RX
Registration Country : USA
Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
Regulatory Info : Dossier Readiness: Q1 2025
Registration Country : Latvia
Brand Name :
Dosage Form : Tablet
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Readiness: Q1 2025
Registration Country : Latvia
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Empagliflozin ; Linagliptin
Dosage Form : Immediate Release Tablet
Dosage Strength : 10MG; 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;850MG
Packaging :
Approval Date : 2025-11-03
Application Number : 208427
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;1GM
Packaging :
Approval Date : 2025-11-03
Application Number : 208427
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : LINAGLIPTIN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2025-11-03
Application Number : 208428
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 2MG; 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 2MG; 850MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 2MG; 1G
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Empagliflozin ; Linagliptin
Dosage Form : Immediate Release Tablet
Dosage Strength : 25MG; 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Linagliptin
Dosage Form : Immediate Release Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Linagliptin ; Metformin Hydrochloride
Dosage Form : Immediate Release Tablet
Dosage Strength : 2.5MG; 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Linagliptin ; Metformin Hydrochloride
Dosage Form : Immediate Release Tablet
Dosage Strength : 2.5MG; 850MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Linagliptin ; Metformin Hydrochloride
Dosage Form : Immediate Release Tablet
Dosage Strength : 2.5MG; 1000MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : TRADJENTA
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2011-05-02
Application Number : 201280
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : JENTADUETO
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;500MG
Packaging :
Approval Date : 2012-01-30
Application Number : 201281
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : JENTADUETO
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;850MG
Packaging :
Approval Date : 2012-01-30
Application Number : 201281
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : JENTADUETO
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;1GM
Packaging :
Approval Date : 2012-01-30
Application Number : 201281
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : GLYXAMBI
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG;5MG
Packaging :
Approval Date : 2015-01-30
Application Number : 206073
Regulatory Info : RX
Registration Country : USA
